Dr. Benjamin Wahl
Post-doc
Dr. Benjamin Wahl
Drug Discovery Science
PhD in infection biology, Hannover Medical School (Germany)
Project
Identification of phagocytosis regulators using genome-wide CRISPR screens and single cell RNA sequencing
Supervisor
Dr. Michael Schuler
Dr. Michael Schuler
Principal Scientist, Drug Discovery Science
PhD, University of Constance (Germany)
Research interests:
- RNAi- and Crispr-Cas9-based, genetic screening technologies for target identification/validation and pathway analysis.
- Phenotypic screening technologies combined with high content image and FACS analysis for target identification/validation and compound characterization.